Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Cardiovascular and Hematological Medicine in 2020 – Advances and Insights
Volume: 18 Issue: 1
Author(s): Debabrata Mukherjee
Affiliation:
Export Options
About this article
Cite this article as:
Mukherjee Debabrata , Cardiovascular and Hematological Medicine in 2020 – Advances and Insights, Cardiovascular & Hematological Agents in Medicinal Chemistry 2020; 18 (1) . https://dx.doi.org/10.2174/187152571801200317101055
DOI https://dx.doi.org/10.2174/187152571801200317101055 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Related Journals
Related Books
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
Current Pharmaceutical Biotechnology Statins in Stroke Prevention: Present and Future
Current Pharmaceutical Design Periodontitis and Periodontal Disease - Innovative Strategies for Reversing the Chronic Infectious and Inflammatory Condition by Natural Products
Current Pharmaceutical Design The Effects of Zataria Multiflora on Blood Glucose, Lipid Profile and Oxidative Stress Parameters in Adult Mice During Exposure to Bisphenol A
Cardiovascular & Hematological Disorders-Drug Targets Does Pharmacological Therapy Still Play a Role in Preventing Sudden Death in Surgically Treated Tetralogy of Fallot?
Mini-Reviews in Medicinal Chemistry Exploring N<sup>1</sup>-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
CNS & Neurological Disorders - Drug Targets Pathophysiology of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Editorial: Current Scenario on Natural Products Chemistry
Cardiovascular & Hematological Agents in Medicinal Chemistry Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Statins and Infrainguinal Vascular Bypass Procedures
Current Vascular Pharmacology Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
Current Pharmaceutical Design Urinary Albumin to Creatinine Ratio as Potential Biomarker for Cerebral Microvascular Disease
Current Neurovascular Research Epicardial Adipose Tissue: Another Tassel in the Complex Fabric of Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets High-density Lipoprotein (HDL) Dysfunction and the Future of HDL
Current Vascular Pharmacology Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?
Current Cardiology Reviews Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients
Current Neurovascular Research Drug Metabolism and Transport Under Hypoxia
Current Drug Metabolism Novel Molecular Targets for the Prevention of Fetal Alcohol Syndrome
Recent Patents on CNS Drug Discovery (Discontinued) Safety and Efficacy of Tirofiban as an Adjunctive Therapy for Patients with St-Elevation Myocardial Infarction: A Comparison Versus Placebo and Abciximab
Cardiovascular & Hematological Agents in Medicinal Chemistry Development, Validation, and Application of a High-Performance Liquid Chromatography Method for the Analysis of Dissolution Samples of Telmisartan and Rosuvastatin Calcium Double-Layer Formulation
Current Pharmaceutical Analysis